Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Presight Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Presight Capital

Presight Capital

Operating

Presight Capital: A global venture capital firm investing in early-stage software, frontier tech & biotech sectors.

Location
West Hollywood, CA, US
Founded
2019
Firm
Compare
Portfolio
Employees
Website

Presight Capital is a global venture capital firm that invests in early-stage software, frontier technology, and biotech sectors. The firm takes a comprehensive approach, funding startups from seed to growth stages with investment sizes ranging from $500,000 to $20 million. With over $600 million in assets under management, Presight Capital aims to support the most ambitious founders worldwide.

Notable portfolio companies include AbCellera Biologics, Cleerly, and Perfect Day. Key partners and investors backing Presight Capital include Christian Angermayer's Apeiron, Moore Capital, Point72, Mike Novogratz, Martin Chavez, and Alan Howard. The firm emphasizes a steadfast commitment to outlier entrepreneurs and offers extensive lifecycle support to its portfolio companies.

Presight Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments45
Current Portfolio Count33
Total Portfolio Exits0

Top Investment Stages

Seed14 (35.9%)
Series A10 (25.6%)
Series B8 (20.5%)
Series C4 (10.3%)
Convertible Note3 (7.7%)

Stage Mix

Seed 36%Series A 26%Series B 21%Series C 10%Convertible Note 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Standard Bots logo

Standard Bots

Pantheon Design logo

Pantheon Design

Duetti logo

Duetti

Parker logo

Parker

Alaan logo

Alaan

Commons logo

Commons

Alto Neuroscience logo

Alto Neuroscience

Alloy Therapeutics logo

Alloy Therapeutics

Cleerly logo

Cleerly

Mueshi logo

Mueshi

Earth logo

Earth

Enable Medicine logo

Enable Medicine

Rejuveron Life Sciences logo

Rejuveron Life Sciences

SmithRx logo

SmithRx

Cloud Paper logo

Cloud Paper

Koniku logo

Koniku

thirdweb logo

thirdweb

Peek logo

Peek

Blackrock Neurotech logo

Blackrock Neurotech

Grounded Foods logo

Grounded Foods

Perfect Day logo

Perfect Day

Delix Therapeutics logo

Delix Therapeutics

Tmrw Life Sciences logo

Tmrw Life Sciences

Umoja Biopharma logo

Umoja Biopharma

fortú logo

fortú

Presight Capital - Similar Investment Firms

Foresite Capital logo

Foresite Capital

Preface Ventures logo

Preface Ventures

Start Capital logo

Start Capital

start-capital.com

Precursor Ventures logo

Precursor Ventures

precursorvc.com

Inspired Capital Partners logo

Inspired Capital Partners

Outset Capital logo

Outset Capital

outsetcapital.com

Forefront Capital logo

Forefront Capital

Tech Pioneers Fund logo

Tech Pioneers Fund

Beyond Capital logo

Beyond Capital

joinbeyond.co

CapitalX logo

CapitalX

TrueSight Ventures logo

TrueSight Ventures

truesight.vc

Edge Case Capital Partners logo

Edge Case Capital Partners

edgecasecap.com

DFJ Frontier logo

DFJ Frontier

frontiervc.com

Plain Sight Capital logo

Plain Sight Capital

Primera Capital logo

Primera Capital

primeracapital.com

Presight Capital - Classification

Also Known As
  • Presight Capital LTD
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end